Testing a Model of Care for Patients on Immune Checkpoint Inhibitors Based on Electronic Patient-Reported Outcomes: Protocol for a Randomized Phase II Controlled Trial

André Manuel da Silva Lopes   ^{1 *} , MSc ;   Sara Colomer-Lahiguera   ^{1 *} , RN, MSc, PhD ;   Célia Darnac   ^{1, 2 *} , RN, MSc ;   Stellio Giacomini   ^{1 *} , RN, MSc ;   Sébastien Bugeia   ^{3 *} , RN ;   Garance Gutknecht   ^{3 *} , RN ;   Gilliosa Spurrier-Bernard   ^{4 *} ;   Michel Cuendet   ^{5 *} , MSc, PhD ;   Fanny Muet   ^{1 *} , MSc ;   Veronica Aedo-Lopez   ^{6 *} , MSc, MD ;   Nuria Mederos   ^{2 *} , MD ;   Olivier Michielin   ^{3 *} , MD, MSc, PhD ;   Alfredo Addeo   ^{3 *} , MD ;   Sofiya Latifyan   ^{5 *} , MD ;   Manuela Eicher   ^{1, 2 *} , RN, MSc, PhD

¹ Institute of Higher Education and Research in Healthcare, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland

² Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

³ Department of Oncology, Geneva University Hospital, Geneva, Switzerland

⁴ MelanomeFrance, Teilhet, France

⁵ Precision Oncology Center, Lausanne University Hospital, Lausanne, Switzerland

⁶ Peter MacCallum Cancer Centre, Melbourne, Australia

*all authors contributed equally